Stop REMS Abuse - Anti-competitive practices are costing patients billions - you can help!
Learn More
Close

Resources

Find up-to-date information on generics and biosimilars
Filter Resources
REMS Infographic - Biosimilars
Infographic
Jul 25, 2017 | Erica Klinger
Biosimilars: Breaking Down Barriers to Patient Access (REMS)
Video
Jul 25, 2017 | Erica Klinger
Protect & Expand Competition
Video
Jul 25, 2017 | Erica Klinger
Generic Drug Prices vs. Brand Drug Prices
AAM REMS Infographic
Infographic
Jul 25, 2017 | Erica Klinger
REMS - A Hard Pill to Swallow
2017 Generic Drug Access and Savings Report Cover
Report
Jul 25, 2017 | Erica Klinger
Generic Drug Access and Savings Report
AAM 5 Policy Prescriptions - Rx Solutions
Report
Jul 24, 2017 | Erica Klinger
5 Policy Prescriptions
US Generic Savings Map - 2016
Infographic
Jul 20, 2017 | Rebecca Rodrigues
US Generic Savings Map - 2016
2016 AAM Annual Report
Report
Jul 20, 2017 | Rebecca Rodrigues
2016 Annual Report
Press Release
Jul 18, 2017 | Erica Klinger
FDA Meeting: Administering The Hatch-Waxman Amendments
Blocking Patient Access - FDA-mandated Patient safety programs (REMS)
Blog
Jul 18, 2017 | Erica Klinger
Using Safety Programs to Protect Profits, Not Patients
Press Release
Jul 17, 2017 | Erica Klinger
Kristin Murphy Joins AAM - Michael Brzica Promoted to Vice President
AAM Applauds House Passage of FDA User Fee Reauthorization
Press Release
Jul 12, 2017 | Erica Klinger
AAM Applauds House Passage of FDA User Fee Reauthorization